The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson's Disea
Advertisement
Advertisement
Trending on AJMC
1
Trump Terminates Hundreds of SAMHSA Grants, Threatening Mental Health, Addiction Services Nationwide
2
ICHRA Growth Could Reshape Marketplace Risk Pools and Widen Access Disparities: Matthew McGough
3
CenterWell Pharmacy Expands Access to Obesity Medications Through Employer Program: Aleata Postell
4
Teclistamab-Daratumumab Outperforms Standard of Care for R/R Multiple Myeloma
5
